Cyclo Therapeutics Current Assets

Cyclo Therapeutics (CYTH) currently reports a current assets of $3.3M as of September 2024. That compares with $5.5M in the prior-year period — down 40.9% year over year. Use the charts on this page to explore Cyclo Therapeutics's current assets history and peer comparisons.

Cyclo Therapeutics's current assets decreased from $5.5M to $3.3M — a 40.9% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cyclo Therapeutics reported $3.3M in current assets as of September 2024. That compares with $5.5M in the prior-year period — down 40.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $3.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyclo Therapeutics, and consider following CYTH for alerts when major investors trade the stock.

Cyclo Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $3.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTH with unrelated industries.